A synthetic microRNA‐92a inhibitor (MRG‐110) accelerates angiogenesis and wound healing in diabetic and nondiabetic wounds
Year: 2018
Type: article
Source: Wound Repair and Regeneration
DOI: 10.1111/wrr.12660
Institution: Miragen Therapeutics (United States)
Language: English
Topic: Wound Healing and Treatments
Subfield: Surgery
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2885395939
